Previous studies demonstrated that GDNF improves behavioral functions, promotes neurogenesis, reduces infarct size, increases synaptic plasticity, and decreases apoptosis when applied as a recombinant protein, a TAT-fusion protein or via a viral vector in the post-acute phases of stroke [ 10, 21, 24 ]. Here, GDNF is linked to stroke disorder.